TSP1 has been shown to bind and activate latent TGF-β, thereby modulating TGF-β-stimulated signaling in various diseases, including diabetes, liver fibrosis, pulmonary arterial hypertension, arterial stiffening, cardiomyopathy, and tumors [248]. Here, TGFB1 is linked to pulmonary arterial hypertension.